RY 137.78 -0.2173% TD 79.12 0.4571% SHOP 98.5 0.0406% CNR 178.05 -0.7967% ENB 47.285 0.0953% CP 118.9 -1.3032% BMO 129.94 -0.5967% TRI 211.37 0.8637% CNQ 109.75 -2.5397% BN 54.31 1.3624% ATD 75.79 0.4506% CSU 3700.0 1.9287% BNS 67.02 -0.0298% CM 66.71 -0.67% SU 52.485 -2.3717% TRP 50.495 -0.6591% NGT 53.52 0.131% WCN 229.67 -0.2865% MFC 32.5 -1.4554% BCE 44.87 0.1116%

Aurora Spine Corp

Healthcare CA ASG

0.3CAD
-0.01(3.23%)

Last update at 2024-04-11T19:46:00Z

Day Range

0.280.30
LowHigh

52 Week Range

0.230.47
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -1.50147M -2.35933M -0.23209M -1.25427M -0.06820M
Minority interest - - - - -
Net income -1.50147M -2.35933M -0.23209M -1.25427M -0.06820M
Selling general administrative 7.12M 5.79M 3.76M 4.03M 3.68M
Selling and marketing expenses - - - - -
Gross profit 7.81M 4.83M 3.47M 3.55M 4.59M
Reconciled depreciation 0.87M 0.65M 0.59M 0.39M 0.78M
Ebit - -2.55037M -1.16340M -1.07948M 0.09M
Ebitda -0.46927M -1.90168M -0.57386M -0.69361M 0.86M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.34341M -2.55037M -1.16340M -1.07948M 0.09M
Other operating expenses - - - - -
Interest expense 0.16M 0.00000M 0.00000M 0.17M 0.15M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.16360M -0.15910M -0.08771M -0.17401M -0.14758M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 14.88M 10.54M 8.65M 11.15M 8.68M
Total operating expenses 16.22M 13.10M 9.81M 12.23M 8.59M
Cost of revenue 7.07M 5.71M 5.18M 7.61M 4.09M
Total other income expense net 0.00554M 0.35M 1.02M -0.00078M -0.01205M
Discontinued operations - - - - -
Net income from continuing ops -1.50147M -2.35933M -0.23209M -1.25427M -0.06820M
Net income applicable to common shares - -2.35933M -0.23209M -1.25427M -0.06820M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 10.12M 10.56M 7.16M 6.67M 6.84M
Intangible assets 0.88M 0.85M 0.87M 0.84M 0.85M
Earning assets - - - - -
Other current assets - - - - -
Total liab 5.81M 4.99M 3.87M 4.91M 3.88M
Total stockholder equity 4.32M 5.57M 3.28M 1.77M 2.96M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - 25.09M 22.01M 20.67M 20.66M
Capital stock 25.22M 25.09M 22.01M 20.67M 20.66M
Retained earnings -24.09472M -22.59325M -20.23393M -20.00184M -18.71420M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.42M 3.17M 1.71M 0.44M 0.86M
Cash and equivalents - - - - -
Total current liabilities 3.03M 2.63M 1.56M 2.52M 1.90M
Current deferred revenue - - - - -
Net debt 1.99M - 0.46M 1.69M 1.16M
Short term debt - - - - -
Short long term debt - 0.01M 0.03M 0.03M -
Short long term debt total - - - - -
Other stockholder equity - 3.08M 1.51M 1.10M 1.01M
Property plant equipment - 1.30M 1.09M 1.16M 0.77M
Total current assets 7.33M 8.41M 5.20M 4.68M 5.22M
Long term investments - - - - -
Net tangible assets - 4.71M 2.41M 0.93M 2.10M
Short term investments - - - - -
Net receivables 3.67M 2.67M 1.66M 2.44M 1.58M
Long term debt 2.42M 2.27M 2.14M 2.10M 2.02M
Inventory 3.05M 1.89M 1.60M 1.53M 2.56M
Accounts payable 2.83M 2.45M 1.53M 2.49M 1.87M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 1.62M
Deferred long term asset charges - - - - -
Non current assets total 2.79M 2.16M 1.96M 1.99M 1.62M
Capital lease obligations 0.55M 0.09M 0.17M 0.28M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.87321M -0.72061M -0.55464M -0.28387M -0.27888M
Change to liabilities - 1.04M -0.40360M 0.50M 0.13M
Total cashflows from investing activities - -0.72061M -0.55464M -0.28387M -0.27888M
Net borrowings - -0.19349M -0.14207M -0.13362M -0.03000M
Total cash from financing activities -0.31815M 4.31M 1.51M -0.12862M 0.69M
Change to operating activities - -0.44343M 0.03M -0.04292M 0.25M
Net income -1.50147M -2.35933M -0.23209M -1.25427M -0.06820M
Change in cash -2.74917M 1.46M 1.27M -0.41176M 0.84M
Begin period cash flow 3.17M 1.71M 0.44M 0.86M 0.01M
End period cash flow 0.42M 3.17M 1.71M 0.44M 0.86M
Total cash from operating activities -1.55782M -2.12935M 0.31M 0.00073M 0.44M
Issuance of capital stock 0.00000M 5.12M 1.70M 0.00500M 0.74M
Depreciation 0.87M 0.65M 0.59M 0.39M 0.78M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -1.16453M -0.33360M -0.31589M 0.10M -0.10045M
Change to account receivables - -1.01005M 0.78M -0.85883M -0.77278M
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.88M 0.27M 0.27M -0.02427M
Change to netincome - 0.33M -0.14433M 1.17M 0.21M
Capital expenditures 0.87M 0.72M 0.51M 0.29M 0.29M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.35888M -0.74449M 0.10M -0.29899M -0.48682M
Stock based compensation 0.14M 0.14M 0.09M 0.09M -
Other non cash items 0.23M 0.14M -0.48615M 0.14M 0.14M
Free cash flow -2.43102M -2.84996M -0.24507M -0.28599M 0.14M

Fundamentals

  • Previous Close 0.31
  • Market Cap25.73M
  • Volume29000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.20822M
  • Revenue TTM14.09M
  • Revenue Per Share TTM0.20
  • Gross Profit TTM 4.83M
  • Diluted EPS TTM-0.04

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ASG
Aurora Spine Corp
-0.01 3.23% 0.30 - - 1.83 5.11 2.14 -31.4665
PINK
Perimeter Medical Imaging AI Inc
-0.02 2.41% 0.81 - - 117.72 2.89 122.12 -4.2252
VPT
VentriPoint Diagnostics Ltd
0.005 2.33% 0.22 - - 1376.49 34.01 1193.16 -9.1712
TLT
Theralase Technologies Inc.
0.01 9.09% 0.18 - - 35.41 23.10 36.69 -9.1528
NGMD
NuGen Medical Devices Inc
-0.005 3.85% 0.12 - - 107.75 9.71 118.72 -4.5025

Reports Covered

Stock Research & News

Profile

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L spinal fusion system. Aurora Spine Corporation was founded in 2013 and is headquartered in Toronto, Canada.

Aurora Spine Corp

20 Holly Street, Toronto, ON, Canada, M4S 3B1

Key Executives

Name Title Year Born
Mr. Trent J. Northcutt Founder, Pres, CEO & Director 1967
Mr. Chad Clouse Chief Financial Officer NA
Mr. Laszlo Garamszegi CTO & Founder 1971
Mr. David M. Meyer VP, Chief Legal Officer & Sec. NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).